Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others), By company and By Region
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSerum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others), By company and By Region
The global serum free market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising prevalence of infectious and chronic diseases, demand for cell therapies for cancer treatment and increase in R&D activities are impelling the growth of the market. Serum-free media are media intended to grow a specific cell type or execute a specific application in the absence of serum. The use of serum-free media (SFM) signifies an essential tool, that enables cell culture to be performed with a defined set of conditions as free as possible of confounding variables. The other factors supporting the market’s growth are, increasing demand for various recombinant proteins and types of culture, expanding patient registry for rare disease, easier downstream processing, growing research & development for development of novel therapeutic drugs, expansion of biopharmaceutical industries and biopharma production, adoption of advanced technology, and rise in research and development activities. Also, the increasing strategic growth such as mergers, collaborations, and acquisitions are strengthening the growth of the market.
Rising Prevalence of Infectious and Chronic Diseases
According to the World Health Organization’s (WHO), infectious diseases kill around 17 million people a year
Increasing Biopharmaceutical Production with Adoption of Serum-Free Media
For Instance, in 2019, the Center for Drug Evaluation and Research approved 48 new drugs in which 28% of them were biologics.
Market Segmentation
In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising number of research and development and clinical trials programs in the country.
Market Players
Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
| Segments covered | · Media Type · End User · Company |
| Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa |
| Key companies profiled | Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy